- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
- 10-K Annual report
- 10.10 2016 Inducement Plan
- 10.11 2016 Inducement Plan Option Certificate
- 10.21 Sabella Employment Agreement Amendment
- 10.24 Blank Separation Agreement
- 10.25 Blank Consulting Agreement and Schedule #1
- 10.27 Gesser Offer Letter
- 10.28 Belloff Offer Letter
- 10.51 Catalent Amendment No. 1
- 10.52 Catalent Amendment No. 2
- 21 EX-21
- 23 EX-23
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
- Download Excel data file
- View Excel data file
Exhibit 21
List of Subsidiaries of the Registrant
Acorda Therapeutics Limited (UK)
Acorda Therapeutics Ireland Limited (Ireland)
Biotie Therapies AG (Switzerland)
Biotie Therapies GmbH (Germany)
Biotie Therapies, Inc. (Delaware)
Biotie Therapies Ltd. (Finland) (formerly Biotie Therapies Corp.)
Biotie Therapies International Oy (Finland)
Civitas Therapeutics, Inc. (Delaware)
MS Research & Development Corporation (Delaware)
Neuronex, Inc. (Delaware)
________________________________
Note: Acorda Therapeutics, Inc. subsidiaries may conduct business under the Acorda name as well as under their entity name or variants thereof. Acorda Therapeutics Limited, MS Research & Development Corporation and Neuronex, Inc. are dormant entities without any operations and holding no or de minimis assets.